APRE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $0.69
Market Cap (MRQ) $9M
P/E -0.4
EPS $-1.93
ROE -97.5%
52W Range $1–$2

APRE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1
Ex-date Split Type
Feb. 13, 2023 1-for-20 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
EPS$-1.93
2019-12-31 → 2025-12-31
Free Cash Flow·
2019-12-31 → 2024-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend APRE 5Y avg Peer Median Verdict
P/E -0.45Y avg ≈-1.0 ≈-1.0 · ·
P/B (MRQ) 0.25Y avg ≈0.8 ≈0.8 1.2 Undervalued
Price / Cash Flow -0.45Y avg ≈-1.1 ≈-1.1 · ·
Price / Tangible Book 0.55Y avg ≈5.7 ≈5.7 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 19.5%
Next Report Nov 10, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 10, 2026 $-0.07 $-0.24 70.8%
March 31, 2026 May 13, 2026 $-0.22 $-0.23 6.2%
Dec. 31, 2025 $-0.32 $-0.40 19.6%
Sept. 30, 2025 $-0.47 $-0.35 -36.1%
June 30, 2025 $-0.53 $-0.76 30.3%
Dec. 31, 2024 $-0.49 $-0.70 30.0%
Sept. 30, 2024 $-0.64 $-0.76 15.8%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 12
Metric Trend 20252024202320222021202020192018
R&D Expense ····$24M$38M$21M$14M
SG&A Expense $6M$6M$8M$21M$14M$15M$9M$2M
Operating Expenses $14M$16M$16M$113M$37M$53M$30M$16M
Operating Income $-13M$-14M$-15M$-113M$-37M···
Other Non-op $634.3K$1M$1M$730.2K$319.1K$-667.6K$1M$961.1K
Income Tax $0$0$0$0$0$0$0$0
Net Income $-13M$-13M$-14M$-113M$-37M$-53M$-28M$-16M
EPS (Basic) $-1.93$-2.35$-3.95$-67.99$-34.88$-50.61$-4.67·
EPS (Diluted) $-1.93$-2.35$-3.95$-67.99$-34.88$-50.61$-4.67·
Shares (Basic) 6,538,7225,509,9213,617,6071,657,0551,064,3251,056,6816,002,486·
Shares (Diluted) 6,538,7225,509,9213,617,6071,657,0551,064,3251,056,6816,002,486·
EBITDA $-13M$-14M$-15M··$28.8K$11.1K·
Balance Sheet 19
Metric Trend 20252024202320222021202020192018
Cash & Equivalents $15M$23M$22M$29M$53M$89M$130M$66M
Prepaid Expense $961.9K$726.3K$914.3K$1M$4M$3M$3M$322.1K
Current Assets $16M$24M$23M$30M$57M$92M$133M$66M
PP&E (Net) $59.8K$81.5K$88.4K$2.3K$23.9K$38.5K$41.6K$24.4K
PP&E (Gross) $154.0K$154.0K$138.5K$45.4K$140.9K$152.8K$127.1K$98.8K
Accum. Depreciation $94.2K$72.4K$50.1K$43.1K$117.0K$114.3K$85.4K$74.3K
Other Non-current Assets $271.2K$281.7K··$29.4K$29.4K$107$111
Total Assets $16M$24M$23M$30M$57M$93M$134M$66M
Accounts Payable $713.7K$1M$2M$842.8K$2M$5M$2M$2M
Current Liabilities $3M$3M$4M$3M$7M$15M$9M$5M
Capital Leases ·····$78.8K$302.6K·
Total Liabilities ···$3M$7M$15M$9M$5M
Common Stock $8.2K$5.5K$3.7K$2.7K$1.1K$21.2K$21.0K$127.1K
Paid-in Capital $357M$351M$336M$330M$241M$231M$226M$20M
Retained Earnings $-334M$-321M$-308M$-294M$-181M$-144M$-91M$-62M
AOCI $-11M$-11M$-11M$-11M$-10M$-10M$-12M$-9M
Stockholders' Equity $12M$19M$17M$26M$50M$77M$124M$-51M
Liabilities + Equity $16M$24M$23M$30M$57M$93M$134M$66M
Shares Outstanding 8,192,5385,481,0553,736,6732,655,2691,092,96721,186,82721,022,7521,155,366
Cash Flow 9
Metric Trend 20252024202320222021202020192018
D&A $21.7K$22.3K$7.1K$4.4K$12.8K$28.8K$11.1K$8.3K
Other Non-cash $-316.6K$-620.3K$2M··$12M$1M·
Operating Cash Flow $-13M$-14M$-12M$-25M$-38M$-42M$-27M$-15M
CapEx ·$15.5K$93.1K··$25.7K$30.9K$3.7K
Investing Cash Flow ·$-15.5K$-93.1K··$-25.7K$-30.9K$-3.7K
Stock Issued $5M$16M$6M$683.0K$2M···
Net Stock Activity $5M$16M$6M·····
Financing Cash Flow $5M$15M$5M$683.0K$2M$150.9K$93M$56M
Free Cash Flow ·$-14M$-12M··$-42M$-27M·
Profitability 2
Metric Trend 20252024202320222021202020192018
ROA -63.1%-55.6%-54.1%··-47.2%-28.1%·
ROE -97.5%-62.8%-76.7%··-64.3%-105.0%·
Liquidity & Solvency 2
Metric Trend 20252024202320222021202020192018
Current Ratio 5.67.05.1··6.014.7·
Quick Ratio 5.36.84.9··5.814.4·
Per Share 4
Metric Trend 20252024202320222021202020192018
Book Value / Share $1.52$3.52$4.54··$3.65$5.91·
Cash Flow / Share $-1.97$-2.46$-3.37·····
Cash / Share $1.78$4.17$5.78··$4.20$6.19·
EPS (TTM) $-1.93$-2.35$-3.95$-67.99$-34.88$-50.61$-4.67·
Valuation (TTM) 8
Metric Trend 20252024202320222021202020192018
Net Income TTM $-13M$-13M$-14M$-113M$-37M$-53M$-28M·
Market Cap $7M$18M$18M··$2.08B$19.29B·
P/E -0.4-1.4-1.2-0.1-1.6-1.9-196.5·
P/B 0.60.91.0··26.9155.3·
P / Tangible Book 0.60.91.00.725.326.9··
P / Cash Flow -0.5-1.3-1.4··-49.9-722.4·
P / FCF ·-1.3-1.4··-49.8-721.6·
Earnings Yield -226.3%-71.4%-84.0%-1027.0%-60.8%-51.4%-0.51%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Net Income $-13M $-13M $-14M $-113M $-37M
Diluted EPS $-1.93 $-2.35 $-3.95 $-67.99 $-34.88

Institutional owners (13F) 28 filers · $2.0M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 28
Value held $2.0M
New positions 7
Exited positions 2
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
7 (0 vs prior Q) 2 (-3 vs prior Q) 5 (+1 vs prior Q) 5 (0 vs prior Q) +126K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
AIGH Capital Management LLC $814,768 1,015,541 41.75% Shares
Vestal Point Capital, LP $280,805 350,000 14.39% Shares
SPHERA FUNDS MANAGEMENT LTD. $216,621 270,000 11.10% Shares
Nantahala Capital Management, LLC $165,081 205,760 8.46% Shares
RENAISSANCE TECHNOLOGIES LLC $84,883 105,800 4.35% Shares
GEODE CAPITAL MANAGEMENT, LLC $60,072 74,869 3.08% Shares
VANGUARD GROUP INC $49,548 58,086 2.54% Shares
CITADEL ADVISORS LLC $47,015 58,600 2.41% Shares
BNP PARIBAS FINANCIAL MARKETS $36,273 45,211 1.86% Shares
DIADEMA PARTNERS LP $36,029 44,907 1.85% Shares
VANGUARD FIDUCIARY TRUST CO $30,848 38,464 1.58% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $28,032 34,939 1.44% Shares
MORGAN STANLEY $20,723 25,830 1.06% Shares
VANGUARD CAPITAL MANAGEMENT LLC $18,351 22,882 0.94% Shares
LPL Financial LLC $12,879 16,052 0.66% Shares
HighTower Advisors, LLC $11,123 13,864 0.57% Shares
NORTHERN TRUST CORP $10,996 13,705 0.56% Shares
Persistent Asset Partners Ltd $9,218 11,490 0.47% Shares
XTX Topco Ltd $8,476 10,565 0.43% Shares
BlackRock, Inc. $5,755 7,173 0.29% Shares
Tower Research Capital LLC (TRC) $2,880 3,590 0.15% Shares
GROUP ONE TRADING LLC $463 577 0.02% Shares
BARCLAYS PLC $379 473 0.02% Shares
OSAIC HOLDINGS, INC. $236 295 0.01% Shares
WealthCollab, LLC $127 158 0.01% Shares
FMR LLC $36 45 0.00% Shares
SBI Securities Co., Ltd. $13 16 0.00% Shares
UBS Group AG $2 3 0.00% Shares

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
HealthCap VII, L.P., HealthCap VII GP S.A. ×4 filings Nov. 15, 2022 · Initial filing · SEC
5AM Ventures IV, L.P., 5AM Co-Investors IV, L.P., 5AM Partners IV, LLC, 5AM Opportunities I, L.P., 5AM Opportunities I (GP), LLC, Dr. John D. Diekman, Andrew J. Schwab, Dr. Scott M. Rocklage ×6 filings Feb. 16, 2021 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 23 insiders · 8 officers · 17 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Oren Gilad President/CEO March 12, 2026 A 393,895 2 0 $49,901
John P. Hamill SrVP/CFO/Prin Fin & Acct Ofcr March 31, 2026 P 43,528 3 0 $35,965
Scott M Coiante SVP, Chief Financial Officer July 28, 2022 A 145,065 0 0 $0
Gregory Alan Korbel SVP, Chief Operating Officer July 28, 2022 A 45,762 0 0 $0
Nadeem Q. Mirza Chief Medical Officer May 1, 2024 A 6,730 0 0 $0
Eyal C. Attar SVP, Chief Medical Officer June 3, 2022 F 57,233 0 0 $0
Lars B. Abrahmsen SVP, Chief Scientific Officer March 10, 2022 A 43,700 0 0 $0
Gregory S. Wessels SVP, Chief Commercial Officer Feb. 25, 2021 A 16,000 0 0 $0
Rifat Pamukcu Director June 16, 2026 A 8,581 0 0 $0
Marc Duey Director June 16, 2026 A 259,290 1 0 $24,892
Gabriela Gruia Director June 16, 2026 A 4,180 0 0 $0
Bernd R. Seizinger Director June 16, 2026 A 48,910 0 0 $0
Michael Grissinger Director June 16, 2026 A 6,024 0 0 $0
Richard Peters Director June 16, 2026 A 6,254 1 0 $100,371
Jean-Pierre Bizzari Director June 16, 2026 A 4,180 0 0 $0
John B Henneman III Director June 16, 2026 A 13,364 0 0 $0
Christian S Schade Director July 28, 2022 A 259,246 0 0 $0
Fouad Namouni Director June 30, 2021 A 4,610 0 0 $0
Michael Aaron Kelly Director June 30, 2021 A 4,610 0 0 $0
Jonathan Hepple Director June 30, 2020 A · 0 0 $0
Johan Christenson Director June 30, 2020 A 2,366,104 0 0 $0
Scott M. Rocklage Director June 30, 2020 A 75,965 0 0 $0
Guido Magni Director Oct. 7, 2019 P 6,500 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 1 ETF

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 22,882 SH Aug. 19, 2026 Daily

APRE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 10 analysts BUY
Median target $5.00 +619.4%
4 40.0% Strong Buy
5 50.0% Buy
1 10.0% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

3 analysts · 2026-09-29

Mean target $3.73 +437.2%

← Below all targets Current price $0.69
Low$1.20 Mean$3.73 High$5.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
APRE $7M -0.4 · · -97.5% ·
MTVA $19M -1.1 -44.6% -2543.7% -173.5% ·
XCUR $35M -6.9 · · -77.3% ·
SNTI · -0.4 -40.2% · · ·
LGVN · -0.4 -49.9% -1893.6% -247.7% 67.0%
KALA $15M -0.2 · · -1423.8% ·
SNGX $14M -0.6 -85.8% · -311.2% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 12, 2026